Ubs Asset Management Americas Inc Collegium Pharmaceutical, Inc Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 57,016 shares of COLL stock, worth $2.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,016
Previous 94,787
39.85%
Holding current value
$2.62 Million
Previous $2.8 Million
28.84%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding COLL
# of Institutions
259Shares Held
37.6MCall Options Held
53.7KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$266 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.83MShares$130 Million1.63% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.39MShares$110 Million1.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$102 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.6MShares$73.5 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.57B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...